GlassScriptPhysician profile
Nicolas Anthony Wozmak
NPI 1467619353
$3,581.50
in general payments reported to CMS, 2019-2025
12 companies · $469 in 2025
The $469 reported for 2025 was more than what 90% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $416 · 2020: $396 · 2021: $821 · 2022: $589 · 2023: $448 · 2024: $443 · 2025: $469.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,360.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,360.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $2,381.85 | 2019-2025 | (Br5) Peripheral Ivus, IV Other, (Az7) Lasers |
| Abbott Laboratories | $409.40 | 2020-2025 | Armada, Absolute Pro |
| Smith+Nephew, INC. | $272.84 | 2021-2025 | Grafix, Grafix Pl |
| Terumo Medical Corporation | $149.04 | 2019-2022 | |
| Acelrx Pharmaceuticals, INC. | $115.98 | 2019 | |
| Catheter Precision, INC. Fka Ra Medical Systems, INC. | $105.40 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $32.08 | 2025 | Bridion |
| Medtronic, INC. | $30.54 | 2023 | Hawkone |
| Cardinal Health 200 LLC | $27.10 | 2019 | |
| Cardiovascular Systems INC. | $19.97 | 2020 | |
| Cordis US Corp. | $19.01 | 2025 | Mynx Control |
| Takeda Pharmaceuticals U.S.A., INC. | $18.29 | 2023 | Entyvio |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nicolas Wozmak listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.